안국약품

001540KOSDAQ의약품 제조업

55.5 / 100

Reference Date: 2026-04-13

Financial Score23.0 / 40

News Sentiment12.5 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Roughly flat over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

AnKook Pharmaceuticals, established in 1959, is a company specializing in the production and sale of pharmaceuticals and health functional foods, with key products including Sinechura and Levotension. In 2022, sales increased by 16% year-on-year to 271.1 billion KRW, and operating profit rose 32.4% to 6.7 billion KRW, driven by strong market share in respiratory and circulatory drug segments. The company is expanding into AI medical devices and online sales through 'Ewonther' to diversify its business.

Number of Employees

424people

Average Salary

58.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

12.11Industry Average 14.805.0Point

In line with industry avg

PBR

0.63Industry Average 1.045.5Point

Lower than industry avg (good)

ROE

4.42Industry Average 4.424.0Point

In line with industry avg

Debt Ratio

37.13Industry Average 11.980.0Point

3.1x industry avg (risky)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲14.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲39.5% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 5.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (48%)

Current 7,970Won52-week high 9,40052-week low 6,600

1-month return3.0Point

1m 0.5% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral기업가치제고계획(자율공시)2026-03-27
Neutral사업보고서 (2025.12)2026-03-18
Neutral감사보고서제출2026-03-18